Related Experiment Video
Updated: Jul 29, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Challenges and advances in antimicrobial peptide development
Kamila Botelho Sampaio de Oliveira1, Michel Lopes Leite2, Victor Albuquerque Cunha1
1Centro de Análises Proteômicas e Bioquímicas, Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Brazil.
Abstract:
Microbial resistance is a major concern for public health worldwide, mainly because of the inappropriate use of antimicrobials. In this scenario, antimicrobial peptides (AMPs) have emerged as a potential therapeutic alternative means by which to control infectious diseases, because of their broad spectrum of action. However, some challenges can make their clinical application problematic, including metabolic instability and toxicity. Here, we provide a clear description of AMPs as promising molecules for the development of unusual antimicrobial drugs. We also describe current strategies used to overcome the main difficulties related to AMP clinical application, including different peptide designs and nanoformulation.
Insights
Antimicrobial peptides (AMPs) show promise for treating infections, offering a broad-spectrum alternative to conventional drugs. Strategies like novel peptide designs and nanoformulations are being developed to address challenges such as metabolic instability and toxicity for clinical use.
Area of Science:
- Microbiology
- Pharmacology
- Biotechnology
Background:
- Antimicrobial resistance (AMR) is a significant global public health threat.
- Inappropriate antimicrobial use drives the development of resistance.
- Antimicrobial peptides (AMPs) are a potential therapeutic alternative due to their broad-spectrum activity.
Purpose of the Study:
- To describe AMPs as promising molecules for novel antimicrobial drug development.
- To outline current strategies for overcoming AMPs' clinical application challenges.
- To highlight the potential of AMPs in combating infectious diseases.
Main Methods:
- Review of current literature on AMPs.
- Analysis of strategies for enhancing AMP stability and reducing toxicity.
- Exploration of nanoformulation techniques for AMP delivery.
Main Results:
- AMPs possess broad-spectrum antimicrobial properties.
- Metabolic instability and toxicity are key challenges for AMP clinical application.
- Peptide design modifications and nanoformulations show potential for overcoming these hurdles.
Conclusions:
- AMPs represent a promising class of molecules for developing new antimicrobial therapies.
- Advanced design and formulation strategies are crucial for successful clinical translation of AMPs.
- Further research into AMPs is warranted to combat the growing threat of antimicrobial resistance.
More Related Videos
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Microorganisms in Medicine and Therapeutics
Development of Antibiotic Resistance
Transduction